000 01629 a2200445 4500
005 20250513235548.0
264 0 _c20010614
008 200106s 0 0 eng d
022 _a1075-2765
024 7 _a10.1097/00045391-200007010-00004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBasu, S K
245 0 0 _aImproved efficacy and safety of controlled-release diltiazem compared to nifedipine may be related to its negative chronotropic effect.
_h[electronic resource]
260 _bAmerican journal of therapeutics
_cJan 2000
300 _a17-22 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAngina Pectoris
_xdrug therapy
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCalcium Channel Blockers
_xpharmacology
650 0 4 _aCross-Over Studies
650 0 4 _aDelayed-Action Preparations
650 0 4 _aDepression, Chemical
650 0 4 _aDiltiazem
_xpharmacology
650 0 4 _aDouble-Blind Method
650 0 4 _aElectrocardiography
_xdrug effects
650 0 4 _aExercise Test
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNifedipine
_xpharmacology
700 1 _aKinsey, C D
700 1 _aMiller, A J
700 1 _aLahiri, A
773 0 _tAmerican journal of therapeutics
_gvol. 7
_gno. 1
_gp. 17-22
856 4 0 _uhttps://doi.org/10.1097/00045391-200007010-00004
_zAvailable from publisher's website
999 _c11253726
_d11253726